Teleconference
What’s New on the Legal Front in Life Sciences?
Tuesday, October 31 1:00 PM EST to 1:45 PM EST
Teleconference
A major pharmaceutical company is hit with a cyberattack—what are its responsibilities? The opioid epidemic shines a spotlight on drug manufacturers—how should they respond? The life sciences legal landscape is constantly changing, which is why it’s important to remain engaged on the latest news and trends.
Building on the success of our last life sciences teleconference, please join us for our next complimentary 45-minute teleconference.
During the call, we will discuss:
Reconciling IP protection and access to medicines: A client's perspective
Building a compliant opioids marketing program
Protecting your business from current cybersecurity threats
We will take questions from participants at the end of the call. In addition, you are encouraged to send us any questions in advance.
Confirmed speakers include:
Donna M. MeuthEisai Inc., Intellectual Property, Associate General Counsel
**Bruce M. Wexler** (Moderator)Paul Hastings, Intellectual Property, Life Sciences Practice Chair
Jane YoonPaul Hastings, Investigations & White Collar, Life Sciences, Of Counsel
Robert P. SilversPaul Hastings, Privacy & Cybersecurity and Investigations & White Collar, Partner
To register and for event information, please contact:Ngar Eldredgengareldredge@paulhastings.com202.551.1297
Teleconference dial in details will be sent with the event confirmation.
